688 related articles for article (PubMed ID: 28956451)
1. Topical phenytoin nanostructured lipid carriers: design and development.
Motawea A; Borg T; Abd El-Gawad AEH
Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
Rajinikanth PS; Chellian J
Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
[TBL] [Abstract][Full Text] [Related]
3. The impact of topical phenytoin loaded nanostructured lipid carriers in diabetic foot ulceration.
Motawea A; Abd El-Gawad AEH; Borg T; Motawea M; Tarshoby M
Foot (Edinb); 2019 Sep; 40():14-21. PubMed ID: 30999080
[TBL] [Abstract][Full Text] [Related]
4. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
5. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
Shinde UA; Parmar SJ; Easwaran S
Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
9. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
12. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
13. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.
Madan JR; Khobaragade S; Dua K; Awasthi R
Dermatol Ther; 2020 May; 33(3):e13370. PubMed ID: 32250507
[TBL] [Abstract][Full Text] [Related]
14. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
15. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
Kaur N; Sharma K; Bedi N
Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
[TBL] [Abstract][Full Text] [Related]
16. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
17. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
Elnaggar YS; El-Massik MA; Abdallah OY
Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
[TBL] [Abstract][Full Text] [Related]
20. Improved skin delivery of voriconazole with a nanostructured lipid carrier-based hydrogel formulation.
Song SH; Lee KM; Kang JB; Lee SG; Kang MJ; Choi YW
Chem Pharm Bull (Tokyo); 2014; 62(8):793-8. PubMed ID: 25087631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
